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Traumatic brain injury (TBI) is a leading cause of mental and physical disability and 
death in the general population. Neuronal dysfunction and behavioral decline associated with 
TBI can result from membrane instability in neurons, synaptic junctions, glia, endothelial cells 
and intracellular organelles.  Membrane integrity, and reaction to extrinsic insult, are highly 
dependent upon dietary intake of polyunsaturated fatty acids (PUFAs), due to brain accretion of 
long-chain omega-3 PUFAs. The present study was designed to examine the influence of various 
dietary fatty acids on brain long-chain omega-3 PUFA content. Mice were fed one of five diets: 
1) a diet containing corn oil, 2) conventional soybean oil, 3) SDA-enriched soybean oil, 4) 
flaxseed oil, or 5) fish oil for 9 weeks. At the end of the study, brains were removed and frozen 
for subsequent fatty acid analysis via gas chromatography (GC).  GC data were used to 
determine the percent area under the curve for key fatty acids, and these values were used to 
perform statistical analyses (ANOVA).  SDA Soy Oil and Flaxseed Oil diets lowered 
arachidonic acid (AA) relative to all plant oil groups, but not as low as fish oil (p<0.05). 
Conversely, SDA soy and flaxseed oil increased docosahexaenoic acid (DHA) relative to all 
other plant oil groups, but not as high as fish oil (p<0.05).  These changes were reflected in the 
n6:n3 ratios, where the results were consistent with the AA findings: SDA Soy oil and flaxseed 
oil produced lower n6:n3 ratios compared to the other plant oil groups, but not as low as fish oil 
(p<0.05). In the present study, SDA-enriched soybean oil and flaxseed oil may represent a 
ii 
sustainable and efficient alternative to marine-based n-3 PUFAs, and could have novel 
therapeutic uses regarding brain related pathologies. 
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CHAPTER 1 
INTRODUCTION 
Dietary importance of polyunsaturated fatty acids (PUFAs) has been a continuous area of 
research concerning various disease states and health outcomes since the early 21st century. 
Nutrient consumption of PUFAs can play an important role in the way the body operates and 
responds under infection, injury, or stress. A factor that contributes to many human disease states 
is inflammation; which is a bodily response under unfamiliar conditions. Clinical studies suggest 
that a balance of select polyunsaturated fatty acids in the diet can help control inflammatory 
processes in the body; therefore possibly mediating the severity of disease. Numerous conditions 
exist that have an inflammatory component such as arthritis, Crohn’s disease, atherosclerosis, 
traumatic brain injury (TBI), type I and II diabetes, and obesity (2). The general population is 
lacking effective treatment strategies for inflammation. As a result, the human diet is receiving 
much attention for new interventions; particularly adequate and balanced PUFA consumption. 
The brain relies on PUFAs to help carry out necessary roles that the body needs. Brain injuries 
increase the importance need for PUFAs to assist with inflammation control and restoring 
normal function (1). In addition, considering 1/3 of adults and 17% of children in the United 
States are currently classified as obese (7). This epidemic alone contributes to the vast amount of 
inflammatory related pathologies today; thus, making it clear that the modern diet is lacking its 
true potential.  
Two subsets of polyunsaturated fatty acids include omega-3 and omega-6. These two 
classes of PUFAs are considered essential nutrients as they need to be acquired through dietary 
consumption or supplementation (8). The types of omega-3 PUFAs discussed here will include 
alpha linolenic acid (ALA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and 
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docosapentaenoic acid (DPA). Omega-6 PUFAs will include linoleic acid (LA), and arachidonic 
acid (AA). Both subsets of polyunsaturated fatty acids contain characteristics that affect 
inflammatory properties within the body. The omega-3 PUFAs consist of anti-inflammatory 
agents whereas omega-6 PUFA’s contribute to pro-inflammatory responses. Certain food sources 
can promote the accretion of these nutrients. Sources of omega 3 PUFAs (EPA/DHA) are found 
in marine-based food such as specific fish and fish oils as well as plant-based foods (ALA) 
including green leafy vegetables, flaxseed, canola, and soybean (24). Omega-6 dietary sources 
are linked to plant oils such as sunflower, safflower, and corn oils. Additionally, animal fat, 
whole-grain breads, and cereal grains contribute to the supply of the omega-6 intake (8). The 
significance of consuming adequate amounts of omega-3 PUFAs is associated with anti-
inflammatory responses on overall health. Specifically, intake of EPA and DHA has contributed 
to a reduced risk of metabolic disease, dyslipidemia, insulin resistance, and inflammation itself. 
Positive health benefits have also been linked with EPA and DHA consumption in relation to 
coronary artery disease (24). DHA specifically has exhibited a prime function in retina and brain 
development during early stages of pregnancy (12). The typical Westernized diet is excessive in 
omega-6 intake and deficient in omega-3.With the help of the agricultural revolution, humans 
now consume vast amounts of cereal grains which in turn make up a large staple in the human 
diet (15-17). “The 2010 Dietary Guidelines for Americans recommend consuming at least two (4 
oz. servings) of fish per week to achieve an average of 250 mg per day of long chain omega-3 
fatty acids” (13). According to the Nutrition Journal and data from the National Health and 
Nutrition Examination Survey (NHANES), 2003-2008, results indicated that “ a large percentage 
of the U.S. population is not meeting recommendations for omega-3 fatty acid consumption” 
(14).   
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 In addition to the population failing to meet these recommendations, alternative plant-
based sources such as flaxseed, canola, and soybean as discussed before do not efficiently 
provide optimal tissue levels of EPA and DHA omega-3 PUFA’s. Although they offer higher 
amounts of Alpha Linolenic Acid (ALA), in order to acquire any amount of EPA and DHA from 
these plant based sources, the multistep conversion of ALA to SDA to EPA/DHA must occur. 
This conversion process in the body is not extremely cost effective with a low rate of 0.01%-8% 
in males and 21% in females (24). However, there is potentially a more effective way for this 
conversion to occur. Recently, Stearidonic acid (SDA) has been produced through biotechnology 
and given the Generally Recognized as Safe (GRAS) status by the FDA. In comparison to 
marine-based sources, supplementation of SDA through enriched soybean oil is highly cost 
effective and viable. It has 6-7 times the amount of omega-3 content and 2-3 times less the 
amount of ALA when compared to conventional soybean oil. Furthermore, the substitution of 
SDA for ALA could be a more resourceful way to create end products of EPA and DHA levels 
in tissue. Ultimately, we need to find alternatives to relatively limited supplies of long chain 
omega-3 PUFA sources. SDA enriched soybean oil has been shown to be an easily convertible 
substrate for the synthesis of long chain omega-3 PUFA’s (12, 19).  
 Research has shown diets containing ideal amounts of oily fish intake or fish oil 
supplementation to be the optimal choice for the deposition of long chain (LC) n-3 PUFA in 
tissues (18). Evidence shows that populations or cultures who consume high amounts of fish, 
such as Japanese, have reduced risk of cardiac events (20). According to Calder (2), positive 
anti-inflammatory effects result from both animal models and patients with rheumatoid arthritis 
with fish oil supplementation. In agreement with Calder, there is a substantial amount of data 
(33) to support the beneficial role fish oil plays on various health outcomes. Although research 
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has found the optimal source, reasons such as food preferences, beliefs concerning the 
environment, and non-fish alternatives for fish feed suggest marine sources are not sufficient to 
meet the required American needs (21) for EPA and DHA. SDA enriched soybean oil has been 
viewed as a plausible option. In  2010,  a study published in the American Journal of Nutrition 
examined SDA enriched soybean oil in a randomized, placebo controlled, double blind study 
with 252 overweight adults aged 21-70 years old (in good health). Subjects were given one 
treatment of either soybean oil (control), EPA, or soybean oil enriched with SDA over a 12 week 
period. Comparison of SDA enriched soybean oil versus EPA and conventional soybean oil was 
the focus. Results indicated that SDA enriched soybean oil significantly increased omega-3 
levels according to the erythrocyte EPA concentrations (22). Additionally, Kawabata et al. 
presented a study looking at a variety of SDA diets on rats during a four week testing period. 
Data collection revealed increased EPA amounts found in serum and liver triacyglycerol levels 
(23). A further study in 2013 by Casey et al. examined lean and obese Zucker rats fed either a 
(control) westernized, flaxseed, fish (menhaden), or SDA oil diet.  Conclusions of metabolic 
effects from these diets after 12 weeks were made in addition to the consistent supporting results 
of increased n-3 PUFA levels in erythrocyte and tissue levels from SDA enriched soybean oil. 
Liver tissue was enriched with n-3 PUFAs while simultaneously decreasing n-6 PUFA. The fish 
oil diet represented the most EPA and DHA content as would be expected (24). That being said, 
we can conclude there is current data supporting liver accretion of n-3 PUFAs. Studies 
examining brain fatty acid levels by means of dietary manipulation are few and are in need of 
further investigation. Long chain omega 3 polyunsaturated fatty acids can make an impact on 
nutrition and health; thus, sufficient dietary sources and recommendations are essential. 
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Accordingly, the present study was designed to examine the influence of various dietary fatty 
acids on brain long-chain omega-3 PUFA content in mice. 
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CHAPTER 2 
METHODS 
 Experimental methods for the current study were comparable to those from Casey et al.  
(24).  Male mice 3-4 weeks of age were allowed free access to one of five experimental diets for 
9 weeks: 1) conventional soybean oil (Soy); 2) SDA-enriched soybean oil (SDA); 3) a diet 
containing corn oil (Corn); 4) flaxseed oil (Flax); or 5) fish oil (Fish). Mice were fasted 
overnight before being fed ad libitum during the experimentation. The housing environment 
consisted of wire cages in a temperature controlled room with a 12 hour light-dark cycle. All 
experimental protocols applied for animal care and use were approved by Animal Care and Use 
Committee of Southern Illinois University Carbondale, IL.   
Experimental diet compositions were adapted from Monsanto US 17 Rodent Diets and 
are listed in Table 1. The diets were designed to be isocaloric and isonitrogenous. The CON diet 
was prepared to resemble the typical Westernized diet with a high omega-6 PUFA and omega-3 
PUFA ratio. SDA enriched soybean oil, corn, flaxseed, and fish diets were modified for omega-6 
PUFA and omega-3 PUFA content.  A percentage variation of each diet was used in order to 
establish consistent saturated and monounsaturated fat content. Thus, the PUFA to saturated fat 
ratio was close to 1.0 for all diets. Brains and livers were harvested and frozen for fatty acid 
analysis. Results are shown in Tables 2-4.  
Tissue Fatty Acid Analysis 
Experimental procedures regarding tissue fatty acid analysis were utilized from Casey et 
al (24). “For this liver and brain tissue samples were measured to 500 mg and put into glass test 
tubes (16×200 mm) with Teflon-lined screw caps, stored at -80°C for 6h, freeze-dried, and then 
methylated using the NaOCH3 and HCl two-step procedure as published previously [30]. 
7 
 
 
Methylated fatty acids were then analyzed for fatty acids using a Shimadzu GC-2010 gas 
chromatograph (Shimadzu Scientific Instruments Inc., Columbia, MD) equipped with a flame 
ionization detector and a Supelco 100-m SP-2560 fused silica capillary column (0.25 mm i.d. × 
0.2 μm film thickness). The helium carrier gas was maintained at a linear velocity of 23 cm/s. 
The oven temperature was programmed for 135°C for 5 min, then increased at 5°C/min to 
165°C, held there for 80 min, then increased at 3°C/min to 180°C, then increased at 5°C/min to 
245°C and held there for 9 min. The injector and detector temperatures were set at 255°C. Peaks 
were identified by comparing the retention times with those of corresponding standards (Nu-
Chek Prep, Elysian, MN; Supelco, Bellefonte, PA; and Larodan Fine Chemicals, Malmo, 
Sweden). Heptadecanoic acid (C17:0) was added to all samples as an internal standard”.  
Statistical Analysis 
 Statistical analyses were performed to test for differences between the means for each of 
the five diet groups. One-way ANOVA using Prism 6.07 for Windows (GraphPad Software, La 
Jolla California USA) was used as well as Tukey’s post-hoc test to compare all groups. For all 
tests, p<0.05 was considered significant.  
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CHAPTER 3 
RESULTS 
Body and Tissue Weight  
As represented in Table 2, no significant differences were reported in final body weight 
or brain weight amongst the diet groups. Liver weights were greater in SDA Soy vs. Soy, Corn, 
Flaxseed, and Fish (p<0.05).  
Brain Fatty Acid Profile  
Results from brain fatty acid profiles demonstrated several significant interactions after 
completion of our statistical analysis as shown in Table 3. Soy and SDA Soy were significantly 
higher in brain LA compared to Corn, Flax, and Fish diets (p<0.0001). We observed no 
significant difference in LA between Soy versus SDA Soy. There were no significant differences 
amongst diet groups on ALA profiles. SDA deposition was significantly higher in Soy compared 
to Corn (p<0.0001), Flax (p=0.0007), and Fish (p=0.0010). SDA Soy was also significantly 
higher when compared to Corn (p=0.0006), Flax (p=0096), and Fish (p=0.9998) diets. When 
comparing Soy versus SDA Soy, we again observed no significant difference. The corn diet 
revealed the highest levels of AA amongst diet groups while Fish revealed the lowest 
(p<0.0001). DPA was significantly higher in Soy or Corn compared to SDA Soy, Flax, and Fish 
(p<0.0001). All other diet comparisons for DPA revealed no significance. We observed no 
significant differences in EPA profiles between diet groups. Fish demonstrated the highest DHA 
amongst all diets groups (p<0.0001). Flaxseed was significantly higher in DHA compared to diet 
groups, but not as high as Fish (p<0.0001).  
Overall, SDA Soy and Flax diets lowered brain AA relative to all plant oil groups, but not 
as low as fish oil (p<0.05).  Conversely, SDA Soy and Flax increased brain DHA relative to all 
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other plant oil groups, but not as high as fish oil (p<0.05).  These changes were reflected in the 
n6:n3 ratios, where the results were consistent with the AA findings: SDA Soy and Flax 
produced lower n6:n3 ratios compared to the other plant oil groups, but not as low as Fish 
(p<0.05).  
Liver Fatty Acid Profile  
Numerous significant differences were revealed after we statistically analyzed the liver 
fatty acid profiles as Shown in Table 4. For example, Soy was significantly higher in liver LA 
compared to Fish (p=0.0105). Fish was significantly lower in LA compared to Corn (p=0.0359). 
All other diet comparisons revealed no significant differences in liver LA. We observed no 
significant differences between diet groups regarding ALA profiles. SDA Soy was significantly 
higher in SDA when compared to all diet groups (p<0.0001).  All other diet comparisons for 
SDA revealed no significance. Flax was significantly lower in AA compared to Corn (p=0.0195) 
and Fish (p=0.0294). All other diet comparisons for AA revealed no significance. Liver EPA 
was significantly highest in Flax compared to all diet groups (p<0.0001). SDA Soy was 
significantly higher in EPA compared to Soy and Corn (p<0.0001). Fish revealed significantly 
higher EPA when compared to Soy, Flax, and Corn (p<0.0001), but not as high as Flax or SDA 
Soy. DPA deposition was significantly higher in Fish compared to Soy and Corn (p<0.0001). 
SDA Soy was less than Fish but higher in DPA versus Soy and Corn (p<0.0001). DHA in the 
liver was highest in Fish and SDA Soy compared to all diet groups (p<0.0001). DHA was 
significantly lower in Corn versus all diet groups except Soy (p<0.0001).  
Overall, Flax decreased liver AA compared to Corn and Fish diets (p<0.05). Regarding 
DHA and DPA, Fish and SDA Soy revealed higher levels (p<0.05). Soy produced higher n6:n3 
ratios compared to all diet groups except Corn (p<0.05).  
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CHAPTER 4 
DISCUSSION 
Dietary intake of long chain omega-3 PUFAs offer nutrition related benefits, as a variety 
of dietary sources are studied today.  As expected, our data suggest fish oil had the greatest 
impact on lowering AA and increasing DHA in the brain as represented in Figure 1 (p<0.0001). 
This relationship was consistent with the findings in liver (Figure 2), where DHA was also 
significantly higher in fish-oil fed mice compared to all other diet groups (p<0.0001). 
Conclusions from the SDA Soy treatment group revealed AA in brain content was significantly 
lower relative to all diet groups, but not as low as flaxseed oil (p<0.0001); Additionally, SDA 
Soy increased DHA in the brain versus Soy and Corn diets, but not as high as flaxseed oil and 
fish oil (p<0.0001). DHA content in liver was significantly higher in SDA Soy compared to all 
diets except for Fish Oil (p<0.0001). Although no significant findings were reported from brain 
EPA levels, liver EPA was highest in flaxseed and SDA Soy (p<0.0001). With previous research 
findings and the data we observed, replacing high omega-6 oils in the diet such as corn, 
sunflower, and conventional soybean oil with omega-3 rich oils like flax and fish oil can assist 
with achieving more balanced ratio of PUFA’s in the tissue.  These findings support additional 
dietary alternatives such as SDA enriched soybean oil that could offer direction to the modern 
diet. 
Previous research studies (26, 29, 30, 32, 31, 25) have been performed in various models 
to examine the influence of dietary SDA and LC n-3 PUFA content in blood and tissue levels. A 
naturally occurring oil containing SDA known as echium oil has most recently become a popular 
area of focus in research. Before discussing various animal studies, a recent human study was 
performed in 2016 comparing echium oil with linseed oil (also known as flaxseed oil). Kuhnt et 
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al. concluded echium oil to better increase amounts of EPA and DPA by 25% in plasma, red 
blood cells (RBC), and peripheral blood mononuclear cells (PBMC) versus linseed oil. A lower 
ratio of AA/EPA in plasma, RBC, and PBMC was also revealed. This study may well suggest 
echium oil is a better alternative than flaxseed oil for increasing EPA and DPA in the blood in 
humans (26). In regards to animal models, broiler chickens SDA-rich echium oil was more 
efficient at increasing EPA and DPA in the blood versus ALA feed (29). These conclusions also 
support substitution of SDA for ALA is a more resourceful way to create end products of n3 
PUFAs in blood and tissues. Examining this effect in the animal model may suggest similar 
results in humans. In addition, research from Miller et al. (30) demonstrated similar conclusions 
in Atlantic salmon. Echium oil increased the biosynthesis elongation products in muscle and 
carcass; suggesting SDA to be a better precursor of LC n-3 PUFA’s. Research from Bharadwaj 
et al. (32) examined LC n-3 PUFA’s in hybrid sea bass fed diets consisting of Fish (CON), ALA, 
or SDA oils at three different levels (.5, 1, and 2%). DHA was significantly higher in fish fed 
SDA diets versus ALA. Thus, proposing a SDA enriched diet may increase DHA concentrations 
in muscle of the hybrid sea bass. Further models such as lamb and rats have been researched as 
well. A 4 week study was conducted by Kitessa et al. (31) examining LC n-3 PUFA’s in lamb 
tissues from stomach infused treatments of saline (CON), echium oil (Low), echium oil (High), 
linseed oil (Low) or linseed oil (High). Results suggested that both echium oil and linseed oil 
increase EPA and DPA in lamb muscle tissues, but not DHA. Furthermore, rats fed a 12 week 
diet of echium oil or fish oil saw increased DPA in tissues (especially in the heart) from echium 
oil and increased levels of DHA in the heart from fish oil; where researchers from the study 
presented SDA oils can increase n-3 PUFA levels in plasma and tissue in rats (25).  
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Further exploration is needed to verify if SDA oils are as strong an influence as fish oils 
on inflammatory response. In addition, very few studies have observed brain LC n-3 PUFA 
content. With marine-based sources being costly and under consumed, new strategies for better 
intake of these vital nutrients are needed. Research has shown LC omega-3 PUFA consumption 
is linked to health benefits such as anti-inflammatory responses; aiding in prevention and 
potential treatment of various disease states. In the present study, SDA-enriched soybean oil and 
flaxseed oil may represent a sustainable and efficient alternative to marine-based n-3 PUFAs, 
and could have novel therapeutic uses regarding brain related pathologies.  
 
 
 
 
 
 
 
 
  
13 
 
 
REFERENCES 
1. Bazan NG, Musto AE, Knott EJ. Endogenous signaling by omega-3 docosahexaenoic acid-
derived mediators sustains homeostatic synaptic and circuitry integrity. Mol Neurobiol 2011; 44 
(2):216-222. 
2. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J 
Clin Nutr. 2006 Jun;83:1505s-19s. 
3. Brown AW, Elovic EP, Kothari S, Flanagan SR, Kwasnica C. Congenital and acquired brain 
injury. 1. Epidemiology, pathophysiology, prognostication, innovative treatments, and 
prevention. Arch Phys Med Rehabil 2008 Mar;89:S3-S8.  
4. Neese SL, Sherill LK, Tan AA et al. Vagus nerve stimulation may protect GABAergic 
neurons following traumatic brain injury in rats: An immunocytochemical study. Brain Res 
2007; 1128(1): 157-163. 
5. Neese SL, Clough RW, Banz WJ, Smith DC. Z-Bisdehydrodoisynolic acid (Z-BDDA): an 
estrogenic seco-steroid that enhances behavioral recovery following moderate fluid percussion 
brain injury in male rats. Brain Res 2010 Nov 29;1362:93-101.  
6. Rustemeyer, J, Kranz V, Bremerich A. Injuries in combat from 1982-2005 with particular 
reference to those to the head and neck: A review. Br J Oral Maxillofac Surb 2007; 45(7): 556-
560.  
7. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the 
United States, 2011-2012. JAMA. 2014;311(8):806-814. 
8. Wall R, Ross RP, Fitzgerald GF, Stanton C. Fatty acids from fish: the anti-inflammatory 
potential of long-chain omega-3 fatty acids. Nutr Rev. 2010 May;68:280-9. 
9. Kris-Etherton PM, Taylor DS, Yu-Poth S, Huth P, Moriarty K, Fishell V, Hargrove RL, Zhao 
G, Etherton TD: Polyunsatruated fatty acids in the food chain in the United States. Am J Clin 
Nutr 2000, 71: 179S-188S. 
10. Burge GC, Jones AE, Wooton SA: Eicosapentaenoic and docosapentaenoic acids are the 
principal products of alpha-linolenic acid metabolism in young men. Br J Nutr 2002, 88: 355-
363. 
11. Burge GC, Wootton SA: Conversion of alpha-linolenic acid to eicosapentaenoic, 
docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr 2002, 88: 411-420. 
12. Deckelbaum RJ, Calder PC, Harris WS, Akoh CC, Maki KC, Whelan J, Banz WJ, Kennedy 
E. Conclusions and recommendations from the symposium, Heart Healthy Omega-3s for Food: 
Stearidonic Acid (SDA) as a Sustainable Choice. J Nutr. United States; 2012. p. 641s-3s. 
13. U.S. Department of Agriculture and U.S. Department of Health and Human Services: Dietary 
Guidelines for American, 2010. 7th Edition, Washington, DC: U.S. Government Printing Office, 
December 2010.  
14 
 
 
14. Papanikolaou Y, Brooks J, Reider C, Fulgoni VL, 3rd. U.S. adults are not meeting 
recommended levels for fish and omega-3 fatty acid intake: results of an analysis using 
observational data from NHANES 2003-2008. Nutr J. 2014;13:31. 
15. Cordain L. Cereal grains: humanity's double-edged sword. World Rev Nutr Diet. 
1999;84:19-73. 
16. Simopoulos AP, Norman HA, Gillaspy JE. Purslane in human nutrition and its potential for 
world agriculture. World Rev Nutr Diet. 1995;77:47-74. 
17. Simopoulos AP. Evolutionary aspects of nutrition and health. Diet, exercise, genetics, and 
chronic disease. World Rev Nutr Diet. 1999; 84 
18. Foster R, Williamson CS, Lunn J. Briefing paper: culinary oils and their health effects. Nutr 
Bull 2009; 34:4-47. 
19. Krul, ES, Lemke SL, Mukherjea R, Taylor ML, Goldstein DA, Su H, Liu P, Lawless A, 
Harris WS, Maki KC. Effects of duration of treatment and dosage of eicosapentaenoic acid and 
stearidonic acid on red blood cell eicosapentaenoic acid content. Prostagladins Leukot Essent 
Fatty Acids. 2012. Jan;86:51-9. 
20. Iso H, Kobayashi M, Ishihara J, Sasaki S, Okada K, Kita Y et al. Intake of fish and n3 fatty 
acids and risk of coronary heart disease among Japanese. Circulation 2006;113:195-202. 
21. Deckelbaum R, Torrejon C. The omega-3 fatty acid nutritional landscape: health benefits and 
sources. J Nutr 2012;142:587S-91S.  
22. Lemke SL, Vicini, JL, Su H, Goldstein DA, Nemeth MA, Krul ES, Harris WS. Dietary 
intake of stearidonic acid-enriched soybean oil increases the omega-3 index: randomized, 
double-blind clinical study of efficacy and safety. Am J Clin Nutr. 2010 Oct;92:766-75. 
23. Kawabata T, Shimoda K, Horiguchi S, Domon M, Hagiwara C, Takiyama M, Kagawa Y. 
Influences of stearidonic acid-enriched soybean oil on the blood and organ biochemical 
parameters in rats. Prostaglandins Leukot Essent Fatty Acids. 2013 Feb;88:179-84.  
24. Casey JM, Banz WJ, Krul ES, Butteiger DN, Goldstein DA, Davis JE. Effect of stearidonic 
acid-enriched soybean oil on fatty acid profile and metabolic parameters in lean and obese Zucer 
rats. Lipids Health Dis. 2013;12:147.  
25. Abeywardena MY, Adams M, Dallimore J, Kitessa SM. Rise in DPA following SDA-rich 
dietary echium oil less effective in affording anti-arrhythmic actions compared to high DHA 
levels achieved with fish oil in Sprague-Dawley rats. Nutrients. 2016 Jan;8. 
26. Kuhnt K, Weiss S, Kiehntopf M, Jahreis G. Consumption of echium oil increases EPA and 
DPA in blood fractions more efficiently compared to linseed oil in humans. Lipids Health Dis. 
2016;15:32. 
27. Mayurasakorn K, Williams JJ, Ten VS, Deckelbaum RJ. Docosahexaenoic acid: brain 
accretion and roles in neuroprotection after brain hypoxia and ischemia. Curr Opin Clin Nutr 
Metab Care. 2011 Mar;14:158-67. 
15 
 
 
28. Farooqui AA. N-3 fatty acid-derived lipid mediators in the brain: new weapons against 
oxidative stress and inflammation. Curr Med Chem. 2012 Feb;19:532-43.   
29. Kitessa SM, Young P. Echium oil is better than rapeseed oil in enriching poultry meat with 
n-3 polyunsaturated fatty acids, including eicosapentaenoic acid and docosapentaenoic acid. Br J 
Nutrition 2009;101:709-15. 
30. Miller MR, Bridle AR, Nichols PD, Carter CG. Increased elongase and desaturase gene 
expression with stearidonic acid enriched diet does not enhance long-chain (n-3) content of 
seawater Atlantic salmon (Salmo salar L.). J Nutr. 2008 Nov;138:2179-85. 
31. Kitessa SM, Young P, Nattrass G, Gardner G, Pearce K, Pethick DW. When balanced for 
precursor fatty acid supply echium oil is not superior to linseed oil in enriching lamb tissues with 
long-chain n-3 PUFA. Br J Nutr. 2012 Jul 14;108:71-9. 
32. Bharadwaj AS, Hart SD, Brown BJ, Li Y, Watkins BA, Brown PB. Dietary source of 
stearidonic acid promotes higher muscle DHA concentrations than linolenic acid in hybrid 
striped bass. Lipids. 2010 Jan;45:21-7. 
33. Walker CG, Jebb SA, Calder PC. Stearidonic acid as a supplemental source of omega-3 
polyunsaturated fatty acids to enhance status for improved human health. Nutrition. 
2013;29(2):363-369. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
16 
 
 
APPENDIX A 
 
 
 
 
 
 
 
 
 
  
Ingredients (g/kg) SOYBEAN SDA CORN FLAXSEED FISH 
 gm% kcal% gm% kcal% gm% kcal% gm% kcal% gm% kcal% 
           
Casein, Sodium 200 800 200 800 200 800 200 800 200 800 
L-Cystine 3 12 3 12 3 12 3 12 3 12 
Corn Starch 240 960 240 960 240 960 240 960 240 960 
Maltodextrin 10 75 300 75 300 75 300 75 300 75 300 
Sucrose 100 400 100 400 100 400 100 400 100 400 
Cellulose 50 0 50 0 50 0 50 0 50 0 
Flaxseed Oil 0 0 0 0 0 0 150 1350 0 0 
Menhaden (Fish)  Oil 0 0 0 0 0 0 0 0 140 1260 
Corn Oil 0 0 0 0 150 1350 0 0 0 0 
Soybean Oil 150 1350 0 0 0 0 0 0 10 90 
SDA Soybean Oil 0 0 150 1350 0 0 0 0 0 0 
           
Protein 23.2 21.0 23.2 21.0 23.2 21.0 23.2 21.0 23.2 21.0 
Carbohydrate 48.6 44.0 48.6 44.0 48.6 44.0 48.6 44.0 48.6 44.0 
Fat 17.1 35.0 17.1 35.0 17.1 35.0 17.1 35.0 17.1 35.0 
Total  100.0  100.0  100.0  100.0  100.0 
 SOY SDA CORN FLAX FISH 
      
Final body weight (g) 32.00 ± 1.23 32.76 ± 1.45 31.72 ± 0.81 30.72 ± 0.60 30.77 ± 0.86 
      
Liver weight (g) 1.13 ± 0.04A 1.32 ± 0.05B 1.05 ± 0.03A 1.05 ± 0.04A 1.09 ± 0.03A 
      
Brain weight (g) 0.42 ± 0.01 0.43 ± 0.00 0.43 ± 0.01 0.42 ± 0.01 0.41 ± 0.00 
      
Table 1: Composition of experimental diets* 
*Adapted from Monsanto US17 Rodent Diets (Research Diets, Inc) 
Table 2: Brain, liver, and final body weight in mice fed experimental diets for 9 weeks. 
 
Different letters represent significance between means as determined by one-way ANOVA and 
Tukey’s post hoc test (p < 0.05). 
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Fatty Acid (% of total) SOYBEAN SDA CORN FLAXSEED FISH 
      
LA [18:2(n-6)] 6.21 ± 0.11A 5.84 ± 0.21B 4.90 ± 0.09C 5.29 ± 0.12C 4.99 ± 0.11C 
      
ALA [18:3(n-3)] 6.22 ± 0.68 6.48 ± 0.59 5.77 ± 0.29 6.33 ± 0.37 6.96 ± 0.59 
      
SDA [18:4(n-3)] 0.38 ± 0.04A 0.34 ± 0.02A 0.23 ± 0.01B 0.25 ± 0.01B 0.25 ± 0.01B 
      
AA [20:4(n-6)] 28.48 ± 0.55A 26.44 ± 0.33B 30.70 ± 0.27C 25.10 ± 0.58B 22.47 ± 0.44D 
      
EPA [20:5(n-3)] 0.61 ± 0.07 0.80 ± 0.04A 0.55 ± 0.03B 0.70 ± 0.05 0.68 ± 0.08 
      
DPA [22:5(n-3)] 9.92 ± 0.44A 6.03 ± 0.18B 9.44 ± 0.27A 5.65 ± 0.10B,C 4.76 ± 0.13C 
      
DHA [22:6(n-3)] 47.36 ± 1.06A 53.50 ± 0.62B 48.46 ± 0.43A 56.26 ± 0.51C 59.64 ± 0.91D 
      
n-6 : n-3 0.53 ± 0.01A 0.49 ± 0.01B 0.56 ± 0.00A 0.44 ± 0.01C 0.38 ± 0.01D 
Different letters represent significance between means as determined by one-way ANOVA and 
Tukey’s post hoc test (p < 0.05). 
 
 
 
Table 3: Brain fatty acid profile in mice fed experimental diets for 9 weeks. 
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Fatty Acid (% of total) SOYBEAN SDA CORN FLAXSEED FISH 
      
LA [18:2(n-6)] 49.80 ± 10.33A 37.28 ± 3.06 44.86 ± 5.80A 42.85 ± 2.62 20.11 ± 1.91 
      
ALA [18:3(n-3)] 22.06 ± 9.76 16.30 ± 5.13 33.10 ± 6.88 18.04 ± 2.27 7.69 ± 2.80 
      
SDA [18:4(n-3)] 2.04 ± 0.28A 5.35 ± 0.46B 1.83 ± 0.16A 1.81 ± 0.13A 1.46 ± 0.20A 
      
AA [20:4(n-6)] 14.69 ± 2.91 10.72 ± 1.30 15.30 ± 1.72A,C 7.56 ± 1.54B 15.79 ± 0.74C 
      
EPA [20:5(n-3)] 
0.84 ± 0.17A 
 
12.88 ± 1.03B 1.19 ± 0.21A 16.45 ± 0.88C 10.47 ± 0.89B 
      
DPA [22:5(n-3)] 1.17 ± 0.23A 3.43 ± 0.34B 0.64 ± 0.16A 2.88 ± 0.37B 3.80 ± 0.12B 
      
DHA [22:6(n-3)] 5.11 ± 0.76A 16.30 ± 1.03B 2.63 ± 0.23A 11.42 ± 1.14C 39.15 ± 2.01D 
      
n-6 : n-3 4.89 ± 1.26A 1.10 ± 0.22B 4.23 ± 1.47 0.88 ± 0.04C 0.57 ± 0.04D 
Different letters represent significance between means as determined by one-way ANOVA and 
Tukey’s post hoc test (p< 0.05). 
 
 
Table 4: Liver fatty acid profile in mice fed experimental diets for 9 weeks 
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